Retinal Imaging Market Trend- Increasing Awareness About Early Diagnosis and Treatment

Rising prevalence of various retinal disorders, increasing elderly population, and high chances of vision loss due to eye diseases are some key factors expected to drive global Retinal Imaging market growth.

Market Dynamics:

Over the recent years, there has been a rapid increase in prevalence of retinal disorders and cases of vision loss due to comorbidities. Retinal imaging is an effective way of assessing health of the eye and underlining conditions. It is a non-invasive and safe method used by optometrists for observing health of the eye. These systems are equipped with high-resolution cameras for capturing digital pictures of optical disks, retina, and blood vessels of the eye.

Request Free Sample Copy (To Understand the Complete Structure of this Report [Summary + TOC]) @

Factors such as rising incidence of retinal diseases such as glaucoma, macular degeneration, diabetic retinopathy, conjunctivitis, and cataract, growing adoption of advanced diagnostics and imaging modalities across hospitals, clinics, ophthalmic centers, ambulatory surgical centers, and rising investments for developing advanced imaging products are expected to drive global market revenue growth during the forecast period.

However, high costs of certain retinal imaging modalities, lack of skilled healthcare professionals and technicians for operating the complex systems, and insufficient funds to deploy the latest imaging modalities are some key factors that can hamper market growth to a certain extent during the forecast period.

COVID-19 Impact Analysis 

  • Social distancing and restrictions severely disrupted businesses and operations
  • Lockdowns caused disruptions in transportation and logistics
  • Impacted manufacturing activities and mining operations globally
  • Took a toll on economy of various countries
  • Caused sudden and drastic downturn in economic activity
  • Disrupted agriculture, fisheries, dairy, and other sectors
  • Caused loss of employment and financial crisis
  • Supply impacts were further compounded owing to reduced disposable income
  • Emergence of variants continue to cause concerns and impact normal routines

Fundus Camera Segment to Account for Largest Revenue Share:

The fundus camera segment is expected to account for largest revenue share between 2020 and 2027 owing to rising prevalence of various retinal diseases, high demand for fundus cameras due to its benefits such as precision and portability, and rapid advancements in fundus camera technology. 

Emergen Research is Offering Limited Time Discount (Grab a Copy at Discounted Price Now) @

Ophthalmic Centers Segment To Register Significant Revenue CAGR:

The ophthalmic centers segment is expected to register significant revenue CAGR during the forecast period owing to large patient pool, steady increase in the number of ophthalmic centers across the globe, and rapid adoption of advanced retinal imaging modalities in many ophthalmic centers. 

North America to Lead In Terms of Revenue Share:

North America is expected to dominate other regional markets in terms of revenue share over the forecast period owing to increasing prevalence of eye diseases, rising availability of advanced retinal imaging technology, and presence of well-established healthcare infrastructure and facilities. In addition, presence of leading companies, rising awareness about early diagnosis, increasing geriatric population, and high focus on developing advanced imaging solutions are expected to fuel North America market growth during the forecast period. 

Major Companies in the Market Include:

  • Olympus
  • Robert Bosch GmbH
  • Eyenuk, Inc.
  • Imagine Eyes
  • Optos, Plc.
  • Forus Health Pvt. Ltd.
  • Phoenix Technology Group, Inc.
  • Topcon Corporation
  • NIDEK Co. Ltd.
  • Epipole, Ltd.
  • Others

Browse Full Report Description + Research Methodology + Table of Content + Infographics@

For the purpose of this report, Emergen Research has segmented the global molecular imaging market on the basis of product type, application, end-users, and region:

Device Type Outlook (Revenue, USD Billion; 2017–2027)

  • Fundus Camera
  • Fluorescein Angiography
  • Optical Coherence Tomography (OCT))

End-user Outlook (Revenue, USD Billion; 2017–2027)

  • Hospitals
  • Clinics
  • Ophthalmic Centers
  • Ambulatory Surgical Centers
  • Others

Regional Outlook (Revenue, USD Billion; 2017–2027)

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of APAC
  • Latin America
    • Brazil
    • Rest of LATAM
  • Middle East & Africa
    • Saudi Arabia
    • U.A.E.
    • South Africa
    • Turkey
    • Rest of MEA

Looking to Purchase Reports in Bundle [Schedule a Call with An Analyst]@

Read our Publication on different Websites:

Emergen Research n49 Account

Emergen Research slashdot Account

Emergen Research telegra Account

Emergen Research contently Account

Emergen Research wattpad Account

Emergen Research goodreads Account

About Emergen Research

Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trend’s existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.

Contact Us:

Eric Lee

Corporate Sales Specialist

Emergen Research | Web:

Direct Line: +1 (604) 757-9756


Visit for More Insights:

Explore Our Custom Intelligence services | Growth Consulting Services


Back to news